Field of the Invention
The present invention is directed to an instrument assembly and method of use and application in the treatment of heart valve malfunction. In more specific terms the instrument assembly is specifically adapted to treat mitral regurgitation by means of a direct entry of the instrument through the atrial wall rather than through the vascular system, in order to apply sufficient tension to a prolapsing leaflet, including the anterior leaflet and/or the posterior leaflet of the mitral valve, in order to overcome mitral regurgitation.
Description of the Related Art
The human heart is a four chambered pump that moves blood efficiently through the vascular system. During normal operation, blood enters the heart through the vena cava and flows into the right atrium. Thereafter, blood flows from the right atrium through the tricuspid valve and into the right ventricle. Upon contraction of the right ventricle, blood is forced through the pulmonic valve and into the lungs for oxygenation. The oxygenated blood returns from the lungs and enters the heart through the left atrium and passes through the mitral valve into the left ventricle. Upon contraction of the left ventricle the blood therein flows through the aortic valve and into the aorta and throughout the vascular system.
The mitral valve is disposed in flow regulating communication between the left atrium and the left ventricle. It is composed of two valve leaflets, the mitral valve annulus, which forms a ring that supports the valve leaflets; papillary muscles, which tether the valve leaflets to the left ventricle wall, by preventing them from prolapsing back into the left atrium. Chordae tendineae serve to connect the mitral valve leaflets to the papillary muscles thereby further preventing the leaflets from prolapsing back into the left atrium. A dysfunction of any of these components of the mitral valve can cause “mitral regurgitation”. Mitral regurgitation is a disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. This results in abnormal leaking of blood from the left ventricle back into the left atrium, through the mitral valve, when the left ventricle contracts and is a condition known as “mitral regurgitation”. It is generally recognized in the medical profession that mitral regurgitation is the second most common form of valvular heart disease.
As generally set forth above, when properly functioning, the anterior and posterior valve leaflets of the mitral valve overlap during contraction of the left ventricle and prevent blood from flowing back into the left atrium. This overlap of the 2 leaflets leaning upon each other is called the coaptation and absorbs most of the strain on the mitral apparatus during the ventricular contraction. However, when the mitral valve malfunctions, due to various cardiac diseases, the leaflets are no longer coapting resulting in the mitral valve remaining partially open during ventricular contraction. In turn this allows the “regurgitation” of the blood back into the left atrium, as generally set forth above. When the mitral valve does not close hermetically during the ventricular contraction, the aforementioned back flow of blood to the atrium and the pulmonary vasculature, results in a deleterious condition. More specifically, this condition increases the work load to the heart and may lead to heart failure.
Methods of treating conditions relating to the malfunctioning of the heart valve specifically including valve incompetencies, mitral valve leakage and other heart failure conditions may be in various stages of development, such as the extending of an elongate member transverse across a corresponding or affected heart chamber. Each end of the elongate member extends through a wall of the heart such as the septum wall and an oppositely disposed wall portion, wherein first and second anchoring members are connected to corresponding ends of the elongate member but are disposed external of the heart chamber. Connecting clips or the like are applied to the corresponding exterior ends of the elongate member, resulting in the papillary muscles within the chamber to be effectively re-shaped or repositioned. A predetermined force is applied to the heart itself and/or the affected portions of the heart chamber.
Other specific treatments associated with mitral regurgitation sometimes may include the surgical repair or replacement of the mitral valve, resulting in traumatic and frequently dangerous surgical procedures being performed on a patient.
Accordingly, there is a need in the medical arts for appropriate instrumentation and attendant methods of overcoming heart valve malfunctions, specifically including mitral regurgitation.
The present invention is directed to an instrument assembly and attendant method for treating heart valve malfunction. In more specific terms, the instrumentation and method are specifically, but not exclusively, adapted for the treatment of mitral regurgitation. However, for purposes of clarity and in order to emphasize the versatility of the various embodiments of the present invention, the subject instrument assembly and method will be described generically regarding treatment of a predetermined heart valve. In addition, the present invention will be more specifically described in regard to a procedure involving correction of a prolapsing mitral valve leaflet, which may include the anterior mitral valve leaflet and/or the posterior valve leaflet correcting of mitral regurgitation.
Accordingly, the instrument assembly of the present invention includes an introductory sheath formed of a material of sufficient rigidity to facilitate the penetration and passage through various portions of the heart and mitral valve. As such, the introductory sheath may be said to be formed of at least a “semi-rigid” material. However, this term is to be understood to include material having sufficient flexibility to be manipulated or “steered” through and/or along a predetermined path during the delivery of the sheath and associated components of the instrument assembly to predetermined portions of the heart. Moreover, in one preferred embodiment the sheath will be sufficiently maneuverable to pass through the atrial wall into interior portions of the heart such as the left atrium and left ventricle. In addition and as described in greater detail hereinafter, an introduction assembly and a delivery catheter will be used to facilitate the positioning the introductory sheath into the thoracic cavity and through the atrial wall or other preferred exterior locations of the heart wall.
Additional structural operative features of the instrument assembly include the provision and utilization of at least one, or under required circumstances, more than one elongated chord formed of a biocompatible material and being at least partially flexible. The material from which the chord is formed should have sufficient and/or predetermined tensile strength to exert a predetermined tension on the predetermined, prolapsing valve leaflet as the chord extends between a corresponding portion of the heart wall, such as the ventricular wall, as also more fully described hereinafter. The chord is initially housed concentrically within the interior of the introductory sheath, wherein the sheath and the chord are concurrently movable relative to the heart as well as throughout a portion of the interior thereof. As set forth above, the introductory sheath is formed of a material having physical characteristics that allow it to be accurately manipulated so as to be steerable in such a manner that its tip can aim towards the different designated portions of the anterior or posterior mitral valve leaflets that are in the siege of the prolapse.
Also, the exteriorly concentric introductory sheath is movable relative to and along the length of the chord so as to accommodate proper and intended placement and anchoring of the chord within the heart chamber. Therefore, the sheath is movable with the chord into and through predetermined portions of the heart chamber and movable relative to the chord after proper anchoring, securing and/or intended placement of the chord within the heart chamber. Accordingly, the instrument assembly of the present invention also includes an anchor secured to an outer or distal end of the chord. The anchor may also be sufficiently sharpened, pointed or otherwise configured to penetrate an intended heart valve leaflet, such as a prolapsing leaflet of the mitral valve. Further, the penetration and passage of the anchor, the chord, and the introductory sheath substantially through the predetermined valve leaflet may thereby be facilitated.
When properly positioned, the anchor is structured to be secured to a substantially opposing portion of the heart wall, such as the ventricular wall associated with the left ventricle and/or the papillary muscles associated therewith. In order to assure secure anchoring of the distal end of the chord with the corresponding ventricular wall, a gripping structure may be operatively attached to a remainder of the anchor and disposable into an outwardly and/or radially extending orientation. When so disposed, the gripping structure, in combination with the remainder of the anchor, eliminates or significantly restricts the inadvertent detachment of the anchor, and the distal end of the chord attached thereto, from the corresponding ventricular wall portion. In at least one preferred embodiment of the present invention, the anchor and the gripping structure are disposed and applied so as to penetrate the corresponding portion of the ventricular wall but not extend there through. Therefore, the anchored relation of the gripping structure, anchor and the connected distal end of the chord may be defined by a penetration into the interior of the ventricular wall rather than a passage completely there through. Complications associated with sealing and exterior attachment of the chord to the exterior of the ventricular wall are thereby eliminated.
As provided, the present invention further comprises a method of treating heart and valve malfunction utilizing the instrument as generally set forth above. Accordingly, the attendant method comprises, at least in more generic terms, the passing of a portion of the instrument assembly into an intended heart chamber and into penetrating relation to a predetermined valve leaflet, such as a prolapsing leaflet. The sheath, with the chord concentrically disposed on the interior thereof, is passed through the predetermined valve leaflet. Therefore, by virtue of the enclosed disposition of the chord, the chord and sheath will concurrently enter and extend through the predetermined valve leaflet. By manipulation and the application of a positioning force on the sheath, the sheath and the chord will extend across a corresponding heart chamber and into an anchored relation with a substantially opposing portion of the heart wall.
Once the anchor and the connected distal end of the chord are secured to the opposing heart wall portion, the sheath, still concentrically mounted exteriorly of and in enclosing relation to the chord, is withdrawn from heart chamber in which the chord is anchored. More specifically, the sheath is withdrawn by moving relative to and back along the length of the anchored chord in a direction away from the anchor and connected distal end of the chord. The introductory sheath is further withdrawn back through the predetermined valve leaflet while the proximal portion of the chord remains within the valve leaflet. Once the sheath is disposed exteriorly of the valve leaflet and possibly on the exterior of the heart itself, a securing assembly is operatively disposed within the heart chamber in interconnecting relation between a proximal extremity of the chord and the predetermined valve leaflet.
In more specific terms, the securing assembly may include a securing member, which will be mounted on or connected to a proximal portion of the chord and moved along the length thereof into a predetermined, interconnecting position relative to the prolapsing valve leaflet. The position of the securing member will be tailored to and disposed at the exact position needed to achieve correction of the mitral regurgitation, which may be determined by preoperative transoesopageal echography or other preoperative manner, to quantify the occurring mitral regurgitation preoperatively. The securing member then securely interconnects the proximal extremity of the chord to the predetermined valve leaflet and any excess length of the chord will be severed or detached from the proximal extremity of the chord, which is secured to the surface of the leaflet associated with the atrium. The chord is thereby properly tensioned between the opposing, interior corresponding wall portion of the heart and the predetermined valve leaflet so as to overcome the malfunction of the predetermined valve leaflet as explained in more specific details hereinafter.
As emphasized throughout this description, the instrument assembly and attendant method of the present invention is specifically adapted for the treatment of mitral regurgitation. As such, the introductory sheath and the chord, substantially concurrently enter the atrial wall of the left atrium and pass into the interior thereof. Further, the sheath and the chord penetrate and are passed, substantially concurrently, through a prolapsing (flail) anterior or posterior leaflet of the mitral valve into the left ventricle of the heart chamber. Thereafter the sheath and chord are concurrently extended transversely across the left ventricle, wherein the anchor penetrates and is thereby secured in an anchored relation with a substantially opposing portion of the ventricular wall and/or corresponding papillary muscles. The distal end of the chord is connected to the anchor and is thereby secured in an anchored relation to the ventricular wall, by virtue of the penetrating anchor.
Once the distal end of the chord and anchor are in the anchored relation to the ventricular wall, the sheath is withdrawn back along the length of the chord, away from the anchor and the ventricular wall to which the distal portion of the chord is secured. Moreover, the introductory sheath continues to travel back along the length of the chord through the prolapsing anterior or posterior mitral valve leaflet to a location at least exterior to the leaflet, such as within the left atrium and possibly exteriorly of the heart itself.
A securing assembly is then operatively associated with the instrument and is movably disposed along the length of a proximal portion of the chord. In even more specific terms, the movement of the securing assembly and its associated securing member are disposed into an interconnecting position between a proximal extremity of the chord and the mitral valve leaflet penetrated by the chord. As indicated above, proper tensioning is thereby placed on the prolapsing mitral valve leaflet in order to restore a sufficient surface of coaptation between its counterpart, opposing leaflet and maintain the suppressed leaflet in an operative position sufficient to overcome the mitral regurgitation.
Yet another preferred embodiment of the present invention is directed to an instrument assembly and attendant method for treating heart valve malfunction, including mitral valve regurgitation, wherein one of the mitral valves is prolapsing. As further described herein, the treatment procedure of this embodiment involves the positioning of a tensioning cord into the chamber of the heart, preferably through the left atrium. Moreover, the tensioning cord is preferably positioned, using a catheter, sheath and/or other positioning instrument such as, but not limited to, the type set forth above. More specifically, the chord will pass through the mitral valve, preferably through the mitral orifice and between the mitral valve leaflets, into the left ventricle. The distal end of the chord is anchored into the ventricular wall in a position generally opposing the mitral valve being treated. Concurrently, a proximal portion of the synthetic chord remains in a position through the mitral orifice exteriorly of the mitral valve, including at least a part of the proximal portion thereof being disposed in the left atrium.
In order to properly treat a prolapse of affected valve leaflet, the chord is connected to the valve leaflet by securing the proximal portion, more specifically the proximal end thereof to the predetermined mitral valve leaflet. In order to efficiently and effectively accomplish such attachment, this preferred embodiment of the present invention comprises a securing assembly structured to dispose a securing member in interconnecting relation between the proximal end of the chord and the predetermined valve leaflet. Accordingly, the securing assembly comprises a housing including a head portion and a base connected to the housing in a manner which facilitates relative movement of the head portion and the base between an open position and a closed position. Moreover, a capturing area is formed and/or disposed between the head portion and the base when they are in the open position. The disposition, dimension and configuration of the capturing area are such as to facilitate the gripping or other removable but secure engagement of the predetermined leaflet there between. As such, when “gripped” or otherwise removably retained between the head portion and the base as they are moved from the open position towards or into the closed position, the leaflet is disposed and maintained in a “connecting orientation”, as described in greater detail hereinafter. It is further emphasized that the term “closed position” is meant to describe the relative positions of the head portion and the base when they are gripping, engaging or otherwise removably but securely retaining the predetermined leaflet there between. Accordingly, it is recognized the closed position may be used to include the head portion and the base not being disposed in direct confronting or engaging relation to one another.
Additional details of the securing assembly include a positioning member, which may be in the form of a plunger or like structure, capable of being disposed in driving engagement with the head portion. As a result, manipulation of the housing to the extent of moving the positioning member it into a driving engagement with the head portion forces the head portion towards the base and into or towards the closed position and/or in gripping and removably retaining relation to the predetermined valve leaflet disposed within the capturing area. In order to facilitate return orientation of the head portion and base into the open position, when it is intended to release of the predetermined leaflet, a biasing structure is disposed to normally bias head portion into or towards the open position.
The securing assembly also includes a retaining assembly disposed on both the head portion and the base. As such, the retaining assembly is structured to removeably retain the securing member in a position which facilitates the connection of the securing member to the predetermined valve leaflet, before relative movement of the head portion and base and subsequently, as the head portion and base are relatively disposed from the open position and into or towards the closed position.
In more specific terms, the retaining assembly comprises first and second retaining segments each disposed on a different one of the head portion and base. Further, the first and second retaining segments are disposed and structured to removeably retain the first and second segments of the securing member, at least initially in spaced relation to one another, when the head portion and the base are in the open position. As also discussed in greater detail hereinafter, at least one embodiment comprises the first and second securing segments being respectively defined by a penetrating segment and a receiving segment. Therefore, when the penetrating and receiving segments are appropriately disposed in the first and second retaining segments, when in the open position, a proximal portion of the chord is connected to the base, as well as to the second retaining segment associated with the base. Accordingly, an “interconnecting relation” of the securing member relative to the predetermined leaflet comprises the penetrating segment disposed in penetrating relation through the valve leaflet, retained within the capturing area, when the head portion and base are disposed into the closed position.
Moreover, the accompanying method for treating mitral valve regurgitation using the instrument assembly, as generally set forth above, includes connecting the proximal portions of the chord to the securing member and the securing assembly, once the distal end of the chord is anchored in the ventricular wall. As indicated, when the distal end of the chord is anchored to the ventricular wall, the proximal portion of the chord will extend through the mitral orifice, between the valve leaflets, rather than penetrating through a valve leaflet, as with at least some of the preferred embodiments of the present invention, as described above. As such, the proximal portion of the chord is then connected to the valve leaflet by the securing member. Moreover, the proximal portion of the chord is connected to the securing assembly and the penetrating segment and the receiving segment are removably disposed within the corresponding first and second retaining segments, while the head portion and base are in the open position.
Accordingly, the chord will be properly tensioned and connected to the valve leaflet when its distal end is anchored to the ventricular wall and a proximal end of the proximal portion is connected to the predetermined valve leaflet. Such connection comprises the penetration of the penetrating segment through the predetermined valve leaflet and the receiving segment concurrently to the proximal end of the chord be being connected to the receiving segment and the base.
These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
As represented in the accompanying drawings and with specific reference to
The instrument assembly 10 also includes an introductory sheath 14 movable within the delivery tube 12 and an elongated flexible material chord 16. The introductory sheath 14 is concentrically and movably enclosed within the delivery tube 12 and the sheath 14 is movably disposed concentrically about the chord 16. It is emphasized that
Accordingly, the instrument assembly 10 further includes the elongated flexible material chord 16 which may be formed of a synthetic, biocompatible material. An anchor 18 is fixedly secured to the outer or distal end of the chord 16 and is movable therewith relative to the introductory sheath 14. As clearly represented in
Therefore, with further regard to
With further reference to
As schematically represented in
For purposes of clarity,
With initial reference to
In addition, the penetration of the anterior leaflet 38 initially by the anchor 18 will facilitate the penetration and passage, substantially concurrently, of the chord 16 and the introductory sheath 14 through the anterior leaflet 38 as schematically represented. As further represented in
As best represented in
More specifically, once the introductory sheath 14 is removed from the left atrium 32, through the introduction assembly 42, the securing assembly, including securing member 22, will move along the length of the chord 16 as it is introduced into the left atrium 32 such as through the atrium wall via, the introduction assembly 42. As schematically represented, the securing member 22 will be forced, moved, positioned, etc. along the proximal portion or length 16′ of the chord 16 by any appropriate technique and/or appropriate positioning instrument/device, which may be incorporated or operatively associated with the chord 16. Positioning of the securing member 22 will continue until it is disposed in engaging, interconnecting and at least partially protective or sealing engagement with an exterior surface portion of the suppressed anterior mitral valve leaflet 38 located within the left atrium 32. The position of the securing member 22 will be disposed in the exact position, on and along the length of the chord 16 needed to position and or suppress movement of the leaflet 38 to achieve correction of the mitral regurgitation. Such exact positioning may be determined by preoperative transoesopageal echography or other preoperative manner to quantify online mitral regurgitation preoperatively.
With further regard to the positioning of the securing member 22 into the interconnecting relation between the proximal extremity of chord 16 and the anterior leaflet 38. One embodiment may also include a guiding element or sleeve 25, as represented in
With continued reference to
Therefore, as represented in
As schematically represented in
Moreover, the securing assembly 50 of this additional preferred embodiment of the present invention is intended to secure a securing member in attached, interconnecting relation between a proximal portion 116′ or a proximal end 116″ of the cord 116 to the predetermined valve leaflet being treated. Accordingly, the securing assembly 50 includes a housing generally indicated as 52 having a head portion 54 and a base 56 moveably disposed relative to one another between an open position, as represented in
It is of further note that the housing 50, including all of the operative and structural components associated therewith, is sufficiently dimensioned to pass through an appropriately disposed and dimensioned introduction assembly 42 of the type at least generally described above.
Other structural and operative features of the securing assembly 50 includes a biasing structure 60 mounted on the housing 52 in substantially biasing relation to at least the head portion 54 and at least a portion of a retaining assembly generally indicated as 62. As will be explained in greater detail hereinafter with regard to the method of use or operation of the securing assembly 50, the retaining assembly 62 includes a first retaining segment 64 connected to and moveable with the head portion 54, as well as a second retaining segment 66 connected to or mounted to the base 56. As such, retaining assembly 62 is disposed on or connected to both the head portion 54 and base 56 is structured to initially and removeably retain a securing member 68 thereon. Moreover, the securing member 68, as used in combination with the securing assembly 50, includes a multi-part structure, comprising a first or penetrating securing segment 70 and a second or receiving securing segment 72. Each of the first and second securing segments 70 and 72 is structured to assume an interconnecting relation between the cord 116 and more specifically a proximal end 116″ thereof and a predetermined valve leaflet 100 involved in the procedure.
Yet additional features of the securing assembly 50 includes a connecting linkage 74 mounted on the housing 52 and serving to moveably support at least the head portion 54 and structured for the movement of the positioning member or plunger 58. As such, the head portion 54 and/or plunger 58 are collectively disposed from the open position into the closed position.
In addition a severing or disconnecting member 76 is also mounted on the housing in interconnected relation to the head portion 54. The severing member is moveable with the head portion 54 when it is disposed between the open and closed positions. As described with specific reference to
The primary reference to
As represented throughout
Therefore the interconnecting relation of the securing member 68 relative to the predetermined valve leaflet 100 will be such as to effectively grip and or sandwich it between the penetrating securing segment 70 and the receiving securing segment 72. As such, the distal end 116″ of the cord 116 is also at least partially disposed in effectively connected relation with the penetrating segment 70 and receiving segment 72 as also clearly represented in
In addition, the securing member 168 can be disposed in the aforementioned closed relation or gripping engagement relative to the leaflet 100 and proximal end 116″ by the securing assembly 50, substantially as described above, with little or no structural or operational modifications be required.
Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
Now that the invention has been described,
The present application is a continuation in part of U.S. patent application Ser. No. 13/691,087, filed Nov. 30, 2012, which claims the benefit under 35 U.S.C. Section 119(e) of Provisional Patent Application Ser. No. 61/729,152, filed Nov. 21, 2012, and which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3587567 | Schiff | Jun 1971 | A |
4536893 | Parravicini | Aug 1985 | A |
4690134 | Snyders | Sep 1987 | A |
5201742 | Hasson | Apr 1993 | A |
5591170 | Spievack et al. | Jan 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
6063070 | Eder | May 2000 | A |
6206907 | Marino et al. | Mar 2001 | B1 |
6328757 | Matheny | Dec 2001 | B1 |
6425911 | Akerfeldt et al. | Jul 2002 | B1 |
6508828 | Akerfeldt et al. | Jan 2003 | B1 |
6537290 | Adams et al. | Mar 2003 | B2 |
6596012 | Akerfeldt et al. | Jul 2003 | B2 |
6616596 | Milbocker | Sep 2003 | B1 |
6641592 | Sauer | Nov 2003 | B1 |
6682489 | Tenerz et al. | Jan 2004 | B2 |
6712837 | Akerfeldt et al. | Mar 2004 | B2 |
6902522 | Walsh | Jun 2005 | B1 |
6929655 | Egnelöv et al. | Aug 2005 | B2 |
6960220 | Marino et al. | Nov 2005 | B2 |
7044916 | Tenerz et al. | May 2006 | B2 |
7445626 | Songer | Nov 2008 | B2 |
8092363 | Leinsing | Jan 2012 | B2 |
8133168 | Monnet | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8506624 | Vidlund | Aug 2013 | B2 |
8758393 | Zentgraf | Jun 2014 | B2 |
8790394 | Miller | Jul 2014 | B2 |
9566443 | de Canniere | Feb 2017 | B2 |
20020100485 | Stevens et al. | Aug 2002 | A1 |
20020161378 | Downing | Oct 2002 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20040087831 | Michels et al. | May 2004 | A1 |
20040102804 | Chin | May 2004 | A1 |
20040106945 | Thramann et al. | Jun 2004 | A1 |
20040116897 | Aboul-Hosn | Jun 2004 | A1 |
20040138526 | Guenst | Jul 2004 | A1 |
20050137700 | Spence | Jun 2005 | A1 |
20050149108 | Cox | Jul 2005 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060135962 | Kick et al. | Jun 2006 | A1 |
20060241655 | Viola | Oct 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20070055206 | To | Mar 2007 | A1 |
20070135826 | Zaver et al. | Jun 2007 | A1 |
20070162066 | Lyon | Jul 2007 | A1 |
20070239108 | Albrecht et al. | Oct 2007 | A1 |
20070265643 | Beane et al. | Nov 2007 | A1 |
20080033241 | Peh et al. | Feb 2008 | A1 |
20080114342 | Whayne et al. | May 2008 | A1 |
20080140116 | Bonutti | Jun 2008 | A1 |
20080275295 | Gertner | Nov 2008 | A1 |
20090005800 | Franer | Jan 2009 | A1 |
20090105751 | Zentgraf | Apr 2009 | A1 |
20090192598 | Lattouf | Jul 2009 | A1 |
20100042147 | Janovsky | Feb 2010 | A1 |
20100161042 | Maisano et al. | Jun 2010 | A1 |
20100161043 | Maisano | Jun 2010 | A1 |
20100179574 | Longoria et al. | Jul 2010 | A1 |
20100228077 | Lenker et al. | Sep 2010 | A1 |
20100274091 | Rothstein et al. | Oct 2010 | A1 |
20110029071 | Zlotnick et al. | Feb 2011 | A1 |
20110060182 | Kassab et al. | Mar 2011 | A1 |
20110166413 | Alferness | Jul 2011 | A1 |
20110190811 | Shanley | Aug 2011 | A1 |
20120276928 | Shutter | Jan 2012 | A1 |
20120143209 | Brecheen et al. | Jun 2012 | A1 |
20120272452 | Schultz | Nov 2012 | A1 |
20120272495 | Hildebrandt et al. | Nov 2012 | A1 |
20120272497 | Smith | Nov 2012 | A1 |
20120272499 | Schley et al. | Nov 2012 | A1 |
20120272523 | Calla et al. | Nov 2012 | A1 |
20120272555 | Heath | Nov 2012 | A1 |
20120272556 | Brown | Nov 2012 | A1 |
20120272595 | Gallant | Nov 2012 | A1 |
20120272603 | Carbines | Nov 2012 | A1 |
20120272611 | Tsukimoto et al. | Nov 2012 | A1 |
20120272624 | Argeriou et al. | Nov 2012 | A1 |
20120272632 | Lans | Nov 2012 | A1 |
20120272637 | Holland et al. | Nov 2012 | A1 |
20120272652 | Nicholls et al. | Nov 2012 | A1 |
20120272653 | Merrill et al. | Nov 2012 | A1 |
20120272660 | Garrett | Nov 2012 | A1 |
20120272661 | Milburn | Nov 2012 | A1 |
20120272662 | Milburn | Nov 2012 | A1 |
20120272667 | Ferraro et al. | Nov 2012 | A1 |
20120272670 | Choi et al. | Nov 2012 | A1 |
20120272705 | Hlrane | Nov 2012 | A1 |
20120272738 | Klessel et al. | Nov 2012 | A1 |
20120272741 | Xiao et al. | Nov 2012 | A1 |
20120272768 | Schmidt et al. | Nov 2012 | A1 |
20120272780 | Schimings et al. | Nov 2012 | A1 |
20120272815 | Lingel et al. | Nov 2012 | A1 |
20120272817 | Lindh, Sr. et al. | Nov 2012 | A1 |
20120272841 | Heymanns et al. | Nov 2012 | A1 |
20120272843 | Graff | Nov 2012 | A1 |
20120272845 | Loiret-Bernal et al. | Nov 2012 | A1 |
20120272846 | Fleischer et al. | Nov 2012 | A1 |
20120272876 | Bergeron et al. | Nov 2012 | A1 |
20120272893 | Lauerhaas et al. | Nov 2012 | A1 |
20120272968 | Kirschner | Nov 2012 | A1 |
20120272996 | Jimenez et al. | Nov 2012 | A1 |
20120273014 | Tadayon | Nov 2012 | A1 |
20120273064 | Ismert et al. | Nov 2012 | A1 |
20120273078 | Hawwa et al. | Nov 2012 | A1 |
20120273079 | Guclucan | Nov 2012 | A1 |
20120273141 | Miller et al. | Nov 2012 | A1 |
20120273142 | Miller et al. | Nov 2012 | A1 |
20120273143 | Fillmore et al. | Nov 2012 | A1 |
20120273161 | Raver | Nov 2012 | A1 |
20120273174 | Barnes | Nov 2012 | A1 |
20120273178 | Wanni et al. | Nov 2012 | A1 |
20120273209 | Austin et al. | Nov 2012 | A1 |
20120273210 | Arizmendi, Jr. et al. | Nov 2012 | A1 |
20120273214 | Donald et al. | Nov 2012 | A1 |
20120273219 | Hoffman et al. | Nov 2012 | A1 |
20120273220 | Ezekiel et al. | Nov 2012 | A1 |
20120273228 | Allouche | Nov 2012 | A1 |
20120273230 | Patterson et al. | Nov 2012 | A1 |
20120273231 | Whiddon | Nov 2012 | A1 |
20120273232 | O'Blenes | Nov 2012 | A1 |
20120273328 | Sejourne | Nov 2012 | A1 |
20120273358 | Larnoy et al. | Nov 2012 | A1 |
20120273389 | Aziz et al. | Nov 2012 | A1 |
20120273399 | Daboub et al. | Nov 2012 | A1 |
20120273438 | Nordin et al. | Nov 2012 | A1 |
20120273439 | Beavers et al. | Nov 2012 | A1 |
20120273458 | Bret et al. | Nov 2012 | A1 |
20120273467 | Baxter et al. | Nov 2012 | A1 |
20120273470 | Zediker et al. | Nov 2012 | A1 |
20120273513 | Greer, Jr. | Nov 2012 | A1 |
20120273555 | Flak et al. | Nov 2012 | A1 |
20120273580 | Warren et al. | Nov 2012 | A1 |
20120273641 | Gorman et al. | Nov 2012 | A1 |
20120273647 | Moruzzi | Nov 2012 | A1 |
20120273680 | Furry | Nov 2012 | A1 |
20120273843 | Kim | Nov 2012 | A1 |
20120273860 | Chen et al. | Nov 2012 | A1 |
20120273880 | Tenet et al. | Nov 2012 | A1 |
20120273902 | Lin et al. | Nov 2012 | A1 |
20120273955 | Or-Bach et al. | Nov 2012 | A1 |
20120273987 | Belcher et al. | Nov 2012 | A1 |
20120273989 | Graf | Nov 2012 | A1 |
20120273993 | Shoseyov et al. | Nov 2012 | A1 |
20120274001 | Prabhu | Nov 2012 | A1 |
20120274020 | Daboub | Nov 2012 | A1 |
20120274061 | Wilkinson | Nov 2012 | A1 |
20120274065 | Knapp | Nov 2012 | A1 |
20120274066 | Hanbeck | Nov 2012 | A1 |
20120274076 | Kelaiditis et al. | Nov 2012 | A1 |
20120274145 | Taddeo | Nov 2012 | A1 |
20120274198 | Jenek | Nov 2012 | A1 |
20120274202 | Komatsu | Nov 2012 | A1 |
20120274212 | Yu et al. | Nov 2012 | A1 |
20120274256 | O'Rourke | Nov 2012 | A1 |
20120274266 | Yip | Nov 2012 | A1 |
20120274279 | Banos et al. | Nov 2012 | A1 |
20120274280 | Yip et al. | Nov 2012 | A1 |
20120274281 | Kim | Nov 2012 | A1 |
20120274288 | Wegener | Nov 2012 | A1 |
20120274332 | Sinha et al. | Nov 2012 | A1 |
20120274391 | Kim | Nov 2012 | A1 |
20120274395 | Deam | Nov 2012 | A1 |
20120274440 | Meadows et al. | Nov 2012 | A1 |
20120274470 | Sandvick | Nov 2012 | A1 |
20120274477 | Prammer | Nov 2012 | A1 |
20120274769 | Lee | Nov 2012 | A1 |
20120274770 | Lee | Nov 2012 | A1 |
20120274772 | Fosburgh et al. | Nov 2012 | A1 |
20120274870 | Liu | Nov 2012 | A1 |
20120274937 | Hays et al. | Nov 2012 | A1 |
20120274962 | Thomas et al. | Nov 2012 | A1 |
20120275056 | McGuire, Jr. | Nov 2012 | A1 |
20120275057 | McGuire, Jr. | Nov 2012 | A1 |
20120275085 | Wilson et al. | Nov 2012 | A1 |
20120275128 | Takada et al. | Nov 2012 | A1 |
20120275140 | Feinbloom et al. | Nov 2012 | A1 |
20120275236 | Hess et al. | Nov 2012 | A1 |
20120275244 | Do | Nov 2012 | A1 |
20120275247 | Hwang et al. | Nov 2012 | A1 |
20120275248 | Won | Nov 2012 | A1 |
20120275249 | Yang et al. | Nov 2012 | A1 |
20120275298 | Bryant et al. | Nov 2012 | A1 |
20120275299 | Taylor et al. | Nov 2012 | A1 |
20120275338 | Filsfils et al. | Nov 2012 | A1 |
20120275356 | Aharony et al. | Nov 2012 | A1 |
20120275670 | Joglekar | Nov 2012 | A1 |
20120275754 | Krampotich et al. | Nov 2012 | A1 |
20120275841 | Jimenez et al. | Nov 2012 | A1 |
20120275843 | Jimenez et al. | Nov 2012 | A1 |
20120275845 | Etling | Nov 2012 | A1 |
20120275860 | Exline | Nov 2012 | A1 |
20120275861 | Myslowski et al. | Nov 2012 | A1 |
20120275862 | Vitale | Nov 2012 | A1 |
20120275881 | Mueller | Nov 2012 | A1 |
20120275913 | Robertson, Jr. et al. | Nov 2012 | A1 |
20120275924 | Perkinson | Nov 2012 | A1 |
20120275927 | Rhin | Nov 2012 | A1 |
20120275970 | Nash et al. | Nov 2012 | A1 |
20120275999 | Bell et al. | Nov 2012 | A1 |
20120276005 | Yang et al. | Nov 2012 | A1 |
20120276008 | Walkenhorst et al. | Nov 2012 | A1 |
20120276009 | Pfeifer et al. | Nov 2012 | A1 |
20120276011 | Kupussamy et al. | Nov 2012 | A1 |
20120276021 | Kumar et al. | Nov 2012 | A1 |
20120276025 | Florence et al. | Nov 2012 | A1 |
20120276041 | Salamone et al. | Nov 2012 | A1 |
20120276053 | Kim | Nov 2012 | A1 |
20120276061 | Grazia et al. | Nov 2012 | A1 |
20120276062 | Kellar et al. | Nov 2012 | A1 |
20120276064 | Blau et al. | Nov 2012 | A1 |
20120276067 | Westenfelder | Nov 2012 | A1 |
20120276068 | Sabaawy | Nov 2012 | A1 |
20120276069 | Karperien et al. | Nov 2012 | A1 |
20120276071 | Fraser, Jr. | Nov 2012 | A1 |
20120276073 | Schachner et al. | Nov 2012 | A1 |
20120276074 | Scharenberg et al. | Nov 2012 | A1 |
20120276080 | Kinoshita et al. | Nov 2012 | A1 |
20120276084 | Schaumberg et al. | Nov 2012 | A1 |
20120276087 | Schafer et al. | Nov 2012 | A1 |
20120276088 | El-Deiry et al. | Nov 2012 | A1 |
20120276089 | Lee et al. | Nov 2012 | A1 |
20120276101 | Kwak et al. | Nov 2012 | A1 |
20120276103 | Karperien et al. | Nov 2012 | A1 |
20120276104 | Woisetschlager | Nov 2012 | A1 |
20120276110 | Simard | Nov 2012 | A1 |
20120276111 | Hafezi-Moghadam | Nov 2012 | A1 |
20120276126 | Varadhachary et al. | Nov 2012 | A1 |
20120276130 | Margarit Y Ros et al. | Nov 2012 | A1 |
20120276139 | Moormann et al. | Nov 2012 | A1 |
20120276143 | O'Mahony et al. | Nov 2012 | A1 |
20120276144 | Kernodle et al. | Nov 2012 | A1 |
20120276149 | Littman et al. | Nov 2012 | A1 |
20120276150 | Lauritzen et al. | Nov 2012 | A1 |
20120276151 | Lewis et al. | Nov 2012 | A1 |
20120276152 | Hossainy et al. | Nov 2012 | A1 |
20120276161 | Gravagna et al. | Nov 2012 | A1 |
20120276164 | Tuominen et al. | Nov 2012 | A1 |
20120276169 | Kang et al. | Nov 2012 | A1 |
20120276173 | Marcum et al. | Nov 2012 | A1 |
20120276182 | Baker, Jr. et al. | Nov 2012 | A1 |
20120276185 | Hossainy et al. | Nov 2012 | A1 |
20120276188 | Barrows | Nov 2012 | A1 |
20120276189 | Johnson | Nov 2012 | A1 |
20120276193 | Graversen et al. | Nov 2012 | A1 |
20120276201 | Trachtman | Nov 2012 | A1 |
20120276202 | Selim et al. | Nov 2012 | A1 |
20120276203 | Selim et al. | Nov 2012 | A1 |
20120276204 | Remington et al. | Nov 2012 | A1 |
20120276213 | Chen | Nov 2012 | A1 |
20120276218 | Jung et al. | Nov 2012 | A1 |
20120276232 | Marczyk et al. | Nov 2012 | A1 |
20120276237 | Heymanns et al. | Nov 2012 | A1 |
20120276278 | Qiu et al. | Nov 2012 | A1 |
20120276286 | Vijayakumar | Nov 2012 | A1 |
20120276296 | Fieberg et al. | Nov 2012 | A1 |
20120276297 | Cypcar et al. | Nov 2012 | A1 |
20120276304 | Derrien | Nov 2012 | A1 |
20120276330 | Durney et al. | Nov 2012 | A1 |
20120276365 | Petuskey et al. | Nov 2012 | A1 |
20120276375 | Colgan et al. | Nov 2012 | A1 |
20120276381 | Cypcar | Nov 2012 | A1 |
20120276427 | Kim | Nov 2012 | A1 |
20120276463 | Grannell et al. | Nov 2012 | A1 |
20120276465 | Paganelli | Nov 2012 | A1 |
20120276469 | Shizuku | Nov 2012 | A1 |
20120276509 | Iannotti et al. | Nov 2012 | A1 |
20120276518 | Gillis | Nov 2012 | A1 |
20120276522 | Huang et al. | Nov 2012 | A1 |
20120276528 | Cargill et al. | Nov 2012 | A1 |
20120276529 | Galisson et al. | Nov 2012 | A1 |
20120276537 | Kühn et al. | Nov 2012 | A1 |
20120276552 | Lu | Nov 2012 | A1 |
20120276553 | Gronthoe et al. | Nov 2012 | A1 |
20120276554 | Gutteridge et al. | Nov 2012 | A1 |
20120276555 | Kuhn et al. | Nov 2012 | A1 |
20120276558 | Soper et al. | Nov 2012 | A1 |
20120276572 | Shekdar et al. | Nov 2012 | A1 |
20120276581 | Arav et al. | Nov 2012 | A1 |
20120276588 | Hallen-Adams et al. | Nov 2012 | A1 |
20120276591 | Kneissel et al. | Nov 2012 | A1 |
20120276618 | Dayton et al. | Nov 2012 | A1 |
20120276626 | Shogbon et al. | Nov 2012 | A1 |
20120276627 | Kelnar et al. | Nov 2012 | A1 |
20120276628 | Khan et al. | Nov 2012 | A1 |
20120276632 | Strunk et al. | Nov 2012 | A1 |
20120276679 | Wu | Nov 2012 | A1 |
20120276694 | Koezuka et al. | Nov 2012 | A1 |
20120276754 | Cordingley et al. | Nov 2012 | A1 |
20120276887 | Romine et al. | Nov 2012 | A1 |
20120277006 | Kim | Nov 2012 | A1 |
20120277008 | Kitchen et al. | Nov 2012 | A1 |
20120277051 | Cooper et al. | Nov 2012 | A1 |
20120277073 | Bartsch | Nov 2012 | A1 |
20120277093 | Andrew et al. | Nov 2012 | A1 |
20120277110 | Andre et al. | Nov 2012 | A1 |
20120277111 | Crabtree et al. | Nov 2012 | A1 |
20120277112 | Linn et al. | Nov 2012 | A1 |
20120277118 | Bhati et al. | Nov 2012 | A1 |
20120277120 | Serber et al. | Nov 2012 | A1 |
20120277144 | Duckers | Nov 2012 | A1 |
20120277152 | Ringeisen et al. | Nov 2012 | A1 |
20120277155 | VanAntwerp et al. | Nov 2012 | A1 |
20120277156 | Gross et al. | Nov 2012 | A1 |
20120277157 | Hillman | Nov 2012 | A1 |
20120277161 | Agrez et al. | Nov 2012 | A1 |
20120277162 | Krasnoperov et al. | Nov 2012 | A1 |
20120277173 | Eidenberger | Nov 2012 | A1 |
20120277179 | Bhargava | Nov 2012 | A1 |
20120277195 | Banov et al. | Nov 2012 | A1 |
20120277203 | Lasley et al. | Nov 2012 | A1 |
20120277204 | Taniguchi et al. | Nov 2012 | A1 |
20120277205 | Badorc et al. | Nov 2012 | A1 |
20120277210 | Catron et al. | Nov 2012 | A1 |
20120277215 | Ksander et al. | Nov 2012 | A1 |
20120277228 | Sutton et al. | Nov 2012 | A1 |
20120277229 | Bearss et al. | Nov 2012 | A1 |
20120277251 | Palladino et al. | Nov 2012 | A1 |
20120277265 | Deraeve et al. | Nov 2012 | A1 |
20120277269 | Reilly | Nov 2012 | A1 |
20120277271 | Nadeson et al. | Nov 2012 | A1 |
20120277277 | Wallace et al. | Nov 2012 | A1 |
20120277279 | Barnett et al. | Nov 2012 | A1 |
20120277282 | Gotthardt et al. | Nov 2012 | A1 |
20120277288 | Drumm et al. | Nov 2012 | A1 |
20120277307 | Waddell | Nov 2012 | A1 |
20120277309 | Severa et al. | Nov 2012 | A1 |
20120277312 | Mink et al. | Nov 2012 | A1 |
20120277316 | Tillman et al. | Nov 2012 | A1 |
20120277319 | Steigerwald et al. | Nov 2012 | A1 |
20120277324 | Burk et al. | Nov 2012 | A1 |
20120277364 | Lolli et al. | Nov 2012 | A1 |
20120277376 | Baker, Jr. et al. | Nov 2012 | A1 |
20120277382 | Booth et al. | Nov 2012 | A1 |
20120277412 | Furusako et al. | Nov 2012 | A1 |
20120277430 | Taniguchi et al. | Nov 2012 | A1 |
20120277431 | Taniguchi et al. | Nov 2012 | A1 |
20120277451 | Ochiai | Nov 2012 | A1 |
20120277453 | Franklin et al. | Nov 2012 | A1 |
20120277517 | Ivkov et al. | Nov 2012 | A1 |
20120277521 | Chamberlin | Nov 2012 | A1 |
20120277522 | Shalon et al. | Nov 2012 | A1 |
20120277523 | Shalon et al. | Nov 2012 | A1 |
20120277537 | Kucklick et al. | Nov 2012 | A1 |
20120277544 | Fernandes et al. | Nov 2012 | A1 |
20120277546 | Soykan et al. | Nov 2012 | A1 |
20120277567 | Harlev et al. | Nov 2012 | A1 |
20120277572 | Hubbard | Nov 2012 | A1 |
20120277574 | Panescu | Nov 2012 | A1 |
20120277576 | Lui | Nov 2012 | A1 |
20120277578 | Gunday et al. | Nov 2012 | A1 |
20120277582 | Mafi | Nov 2012 | A1 |
20120277584 | Tanaka et al. | Nov 2012 | A1 |
20120277592 | Zelenka et al. | Nov 2012 | A1 |
20120277599 | Greenhut | Nov 2012 | A1 |
20120277600 | Greenhut | Nov 2012 | A1 |
20120277618 | Giftakis et al. | Nov 2012 | A1 |
20120277621 | Gerber et al. | Nov 2012 | A1 |
20120277624 | Cucin | Nov 2012 | A1 |
20120277626 | Burbank et al. | Nov 2012 | A1 |
20120277638 | Skelton et al. | Nov 2012 | A1 |
20120277639 | Pollock et al. | Nov 2012 | A1 |
20120277642 | Smith et al. | Nov 2012 | A1 |
20120277668 | Chawla | Nov 2012 | A1 |
20120277671 | Fuentes | Nov 2012 | A1 |
20120277672 | Pepper et al. | Nov 2012 | A1 |
20120277674 | Clark, III et al. | Nov 2012 | A1 |
20120277693 | Bailey | Nov 2012 | A1 |
20120277716 | Ali et al. | Nov 2012 | A1 |
20120277718 | Campbell et al. | Nov 2012 | A1 |
20120277720 | Humes et al. | Nov 2012 | A1 |
20120277725 | Kassab et al. | Nov 2012 | A1 |
20120277729 | Melsheimer | Nov 2012 | A1 |
20120277730 | Salahieh et al. | Nov 2012 | A1 |
20120277736 | Francischelli | Nov 2012 | A1 |
20120277740 | Wamking et al. | Nov 2012 | A1 |
20120277741 | Davalos et al. | Nov 2012 | A1 |
20120277743 | Vallittu | Nov 2012 | A1 |
20120277746 | Morgan et al. | Nov 2012 | A1 |
20120277749 | Mootien et al. | Nov 2012 | A1 |
20120277752 | Wasielewski | Nov 2012 | A1 |
20120277753 | Linderman et al. | Nov 2012 | A1 |
20120277756 | Ray et al. | Nov 2012 | A1 |
20120277766 | Ferree | Nov 2012 | A1 |
20120277770 | Fenton et al. | Nov 2012 | A1 |
20120277771 | Vaz et al. | Nov 2012 | A1 |
20120277772 | Aben et al. | Nov 2012 | A1 |
20120277773 | Sargeant et al. | Nov 2012 | A1 |
20120277774 | Guo | Nov 2012 | A1 |
20120277776 | Kraemer et al. | Nov 2012 | A1 |
20120277781 | Gertner | Nov 2012 | A1 |
20120277784 | Berez et al. | Nov 2012 | A1 |
20120277785 | Aggerholm et al. | Nov 2012 | A1 |
20120277786 | Mohl | Nov 2012 | A1 |
20120277791 | Abo-Auda et al. | Nov 2012 | A1 |
20120277792 | Teeslink et al. | Nov 2012 | A1 |
20120277793 | Marczyk et al. | Nov 2012 | A1 |
20120277798 | Benson et al. | Nov 2012 | A1 |
20120277800 | Jackson | Nov 2012 | A1 |
20120277807 | Myung et al. | Nov 2012 | A1 |
20120277811 | Lauchner et al. | Nov 2012 | A1 |
20120277812 | Kraus | Nov 2012 | A1 |
20120277814 | Schuler | Nov 2012 | A1 |
20120277820 | Wu et al. | Nov 2012 | A1 |
20120277823 | Gerber et al. | Nov 2012 | A1 |
20120277825 | Mawson et al. | Nov 2012 | A1 |
20120277833 | Gerber et al. | Nov 2012 | A1 |
20120277835 | Della Santina et al. | Nov 2012 | A1 |
20120277837 | Schuler | Nov 2012 | A1 |
20120277843 | Weber et al. | Nov 2012 | A1 |
20120277845 | Bowe | Nov 2012 | A1 |
20120277846 | Schreck et al. | Nov 2012 | A1 |
20120277852 | Shukla et al. | Nov 2012 | A1 |
20120277853 | Rothstein | Nov 2012 | A1 |
20120277854 | Ryan | Nov 2012 | A1 |
20120277855 | Lashinski et al. | Nov 2012 | A1 |
20120277856 | Spenser et al. | Nov 2012 | A1 |
20120277862 | Tornier et al. | Nov 2012 | A1 |
20120277864 | Brodke et al. | Nov 2012 | A1 |
20120277865 | Trieu et al. | Nov 2012 | A1 |
20120277867 | Kana et al. | Nov 2012 | A1 |
20120277872 | Kana et al. | Nov 2012 | A1 |
20120277873 | Kana et al. | Nov 2012 | A1 |
20120277879 | Ripamonti | Nov 2012 | A1 |
20120277880 | Winslow et al. | Nov 2012 | A1 |
20120277882 | Huang et al. | Nov 2012 | A1 |
20120277896 | Uekita et al. | Nov 2012 | A1 |
20120277903 | Schaefer | Nov 2012 | A1 |
20120277939 | Kumar | Nov 2012 | A1 |
20120277940 | Kumar et al. | Nov 2012 | A1 |
20120277949 | Ghimire et al. | Nov 2012 | A1 |
20120277979 | Kato et al. | Nov 2012 | A1 |
20120277998 | Bevilacqua et al. | Nov 2012 | A1 |
20120277999 | Somogyi et al. | Nov 2012 | A1 |
20120278032 | Chen | Nov 2012 | A1 |
20120278098 | Vovan et al. | Nov 2012 | A1 |
20120278099 | Kelly et al. | Nov 2012 | A1 |
20120278123 | Houle | Nov 2012 | A1 |
20120278144 | Popllock et al. | Nov 2012 | A1 |
20120278195 | Joseph | Nov 2012 | A1 |
20120278200 | van Coppenolle et al. | Nov 2012 | A1 |
20120278236 | Jain et al. | Nov 2012 | A1 |
20120278242 | Griffith | Nov 2012 | A1 |
20120278411 | Lavine | Nov 2012 | A1 |
20120278439 | Ahiska et al. | Nov 2012 | A1 |
20120278454 | Stewart et al. | Nov 2012 | A1 |
20120278484 | Westphal | Nov 2012 | A1 |
20120278520 | Barrenscheen et al. | Nov 2012 | A1 |
20120278554 | Eilert | Nov 2012 | A1 |
20120278592 | Tran | Nov 2012 | A1 |
20120278597 | De Atley et al. | Nov 2012 | A1 |
20120278654 | Shen et al. | Nov 2012 | A1 |
20120278657 | Baker et al. | Nov 2012 | A1 |
20120278676 | Teraura | Nov 2012 | A1 |
20120278684 | Eldredge et al. | Nov 2012 | A1 |
20120278689 | Tamo et al. | Nov 2012 | A1 |
20120278760 | Cerny et al. | Nov 2012 | A1 |
20120278771 | Ren | Nov 2012 | A1 |
20120278799 | Starks et al. | Nov 2012 | A1 |
20120278865 | Sawdy | Nov 2012 | A1 |
20120278913 | Fraser | Nov 2012 | A1 |
20120278947 | Guo | Nov 2012 | A1 |
20120278957 | Phan et al. | Nov 2012 | A1 |
20120283758 | Miller | Nov 2012 | A1 |
20130041395 | De Canniere | Feb 2013 | A1 |
20130066275 | De Canniere | Mar 2013 | A1 |
20150148590 | de Canniere | May 2015 | A1 |
Number | Date | Country |
---|---|---|
0577400 | Oct 1999 | EP |
1147743 | Oct 2001 | EP |
1169968 | Jan 2002 | EP |
1222896 | Jul 2002 | EP |
1266626 | Dec 2002 | EP |
1269919 | Jan 2003 | EP |
1254634 | Jul 2003 | EP |
1244725 | Jul 2005 | EP |
1773239 | Mar 2010 | EP |
WO 2012 040865 | Apr 2012 | WO |
WO2012016398 | Sep 2012 | WO |
WO2013023016 | Feb 2013 | WO |
WO 2013036742 | Mar 2013 | WO |
WO2015081053 | Jun 2015 | WO |
Entry |
---|
Mike Blaber, Metals, Non-Metals, and Metalloids, http://www.mikeblaber.org/oldwine/chm 1045/notes/Periodic/Metals/Period06.htm, 1996, accessed May 14, 2015. |
Number | Date | Country | |
---|---|---|---|
20140142687 A1 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
61729152 | Nov 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13691087 | Nov 2012 | US |
Child | 13967647 | US |